Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
IDT Biologika announced the NIAID of the NIH has awarded the company a new Task Order within the 10-year contract to provide manufacturing of five E. coli Master Cell Banks.
read more
Takeda has officially opened a new manufacturing plant at its site at Grange Castle, in Dublin, Ireland.
read more
Onyx Scientific has made a strategic investment to position the company for a commercial API license.
read more
Nosopharm and Evotec announced their partnership aimed at advancing NOSO-502, to the clinical stage, as well as developing a second-generation Odilorhabdin drug candidate.
read more
The FDA has issued warning letters to three repackers of API for significant violations of current good manufacturing practice (CGMP) requirements.
read more
Pii announced the expansion of its commercial team with the additions of Wayne Ideus, Wayne Grellner and Ryan McFarlane.
read more
Cambrex has announced three senior appointments to further support the Contract development and Manufacturing Organization company.
read more
Glenmark has received a CRL from the FDA for Ryaltris™ (olopatadine hydrochloride [665 mcg] and mometasone furoate [25 mcg]), Nasal Spray.
read more
PPS announced the Grand Opening of a new wing at the Riverview site dedicated to the production of HPAPIs with low Occupational Exposure Levels.
read more
AssurX has announced that oral solid dose CDMO TEDOR Pharma has selected the AssurX platform to fully automate their quality and compliance management processes.
read more
Premier Pharmacy Labs is voluntarily recalling all unexpired products, intended to be sterile, due to a lack of sterility assurance.
read more
Gamida Cell and Lonza announced that the companies have entered into a strategic manufacturing agreement.
read more
Axovant Gene Therapies has signed a strategic partnership with Yposkesi a CDMO for preferred access and reserved capacity for cGMP grade viral vector production.
read more
Seqens will open a 366,000-square-foot lab today that is close to Paris and will serve as the company’s center of excellence in its Porcheville facility.
read more
iBio announced the activation of its new cGMP sterile fill-finish services operation via the signing of a supply agreement with a clinical-stage biopharmaceutical company.
read more